[1]
F. F. Farias, E. G. Hilinski, V. A. P. Martins, E. A. Vieira, and L. M. Trujillo, “DIVERGENCES IN REGULATORY REQUIREMENTS FOR COMPOUNDED FORMULATION AND INDUSTRIALIZED MEDICINES”, Infarma, vol. 32, no. 2, pp. 128–136, Jul. 2020.